YEATS4与KAT8互作维持组蛋白H4K16ac修饰促进膀胱癌细胞增殖的作用机制研究
批准号:
82203470
项目类别:
青年科学基金项目(C类)
资助金额:
20.0 万元
负责人:
谢敏儿
依托单位:
学科分类:
肿瘤表观遗传
结题年份:
2024
批准年份:
2022
项目状态:
已结题
项目参与者:
谢敏儿
中文摘要
膀胱癌恶性程度高,表观修饰及转录调节紊乱,目前尚无有效的靶向表观修饰分子的治疗策略。我们前期通过靶向表观遗传调控因子CRISPR-Cas9敲除文库筛选出YEATS4是膀胱癌细胞存活的必需基因之一。预实验显示:敲除YEATS4显著抑制膀胱癌生长;YEATS4与KAT8互作并互相稳定;敲除YEATS4显著降低KAT8蛋白表达、染色质结合及组蛋白H4K16ac修饰;KAT8乙酰化修饰YEATS4并维持其蛋白稳定性。本项目拟:阐明YEATS4与KAT8蛋白相互稳定的机制;研究YEATS4乙酰化修饰对其蛋白稳定性或结合H3K27ac活性的影响;明确YEATS4能否募集KAT8至染色质形成正反馈环;探索阻断YEATS4与KAT8相互作用能否抑制膀胱癌的生长。本项目的完成,将揭示膀胱癌中组蛋白修饰阅读器YEATS4与书写器KAT8互相正向调控并引起表观转录紊乱的新机制,可能为膀胱癌治疗提供新的策略。
英文摘要
Bladder cancer is characterized by a high degree of malignancy, epigenetic and transcriptional disorder without specific therapeutic targets for epigenetic modification molecules. By using CRISPR-based epigenetic screens,we have recently identified YEATS4 as one of the epigenetic regulators that essential for the viability of bladder cancer cells. Our preliminary results showed that depletion of YEATS4 significantly inhibited the proliferation of bladder cancer cells. YEATS4 interacted and stabilized with KAT8. Depletion of YEATS4 dramatically downregulated the expression of KAT8 protein and its chromatin enrichment and decreased the levels of histone H4K16ac. KAT8 acetylated YEATS4 and maintained its protein stability. This proposal aims to clarify the mechanism of mutually stabilization between YEATS4 and KAT8. To determine the effect of acetylation of YEATS4 by KAT8 on its protein stability or its ability to combine with histone H3K27ac. To investigate whether YEATS4 can act as a positive feedback to enhance the recruitment of KAT8 to chromatin. To explore whether it can effectively inhibit the proliferation of bladder cancer cells by disrupting the interaction of YEATS4 and KAT8. We believe that this proposal will reveal a new mechanism of how histone modification reader YEATS4 and writer KAT8 mutually positively regulates and therefore leads to epigenetic transcriptional disorder in bladder cancer, which may provide a new therapeutic strategy for bladder cancer.
膀胱癌是一种常见的肿瘤,其特点是复发率高且缺乏靶向治疗。在此,我们通过 CRISPR-Cas9 文库筛选发现,YEATS4是膀胱癌细胞存活的关键基因,敲除YEATS4显著抑制膀胱癌细胞增殖、克隆形成及体内成瘤能力,这可能与敲除YEATS4抑制DNA损伤修复促进细胞衰老有关。提示YEATS4是膀胱癌的潜在治疗靶点。通过蛋白质稳定性调节因子筛选试验发现,HUWE1 是负责 YEATS4 泛素化和蛋白酶体降解的 E3 连接酶。而组蛋白乙酰基转移酶KAT8特异性乙酰化修饰YEATS4 K64,65,66位点,增强其蛋白稳定性。进一步,我们发现,KAT8介导的 YEATS4 乙酰化会削弱YEATS4与 HUWE1 的相互作用,从而阻止其泛素化和降解。YEATS4 和 KAT8 的蛋白表达水平呈正相关,且这两种蛋白表达水平高与膀胱癌患者的总体生存率低相关。为探索研究阻断YEATS4乙酰化能否抑制膀胱癌生长,我们使用 KAT8 抑制剂 MG149 处理细胞,发现其可降低 YEATS4 乙酰化水平,降低细胞活力,并使膀胱癌细胞对顺铂治疗更敏感。这些发现揭示了 KAT8/YEATS4 轴在膀胱癌细胞的肿瘤生长和顺铂敏感性中的关键作用,可能为膀胱癌患者提供一种新的治疗策略。
国内基金
海外基金